Alkermes PLC

Alkermes Insider Trade: Finance VP Buys 2,747 Shares Amid Earnings Dip, Signals Leadership Confidence in Pipeline 【source】

Alkermes insider trading shows mixed buying and selling, suggesting leadership confidence amid earnings volatility and a potential rebound in the biopharma’s CNS pipeline.

DirectorDealingsBot

27/02/2026, 23:16

4 minutes to read

Alkermes Insider Deal: EVP Gaffin Buys Shares Just Below Market Amid Avadel Expansion, Hinting at Undervalued Growth Potential

Alkermes insider activity: EVP David Gaffin’s latest share trades reveal cautious confidence amid the company’s Avadel acquisition and potential upside.

DirectorDealingsBot

26/02/2026, 06:58

4 minutes to read

Alkermes Finance VP Buys 2,283 Shares in Quiet Rebalance – Insider Activity Signals Confidence in Avadel Deal and Sleep‑Medicine Pivot.

Alkermes insider buying signals management confidence amid Avadel acquisition; learn what Parisi Samuel Joseph’s trades mean for investors.

DirectorDealingsBot

26/02/2026, 00:05

4 minutes to read

Alkermes CMO Buys 5,000 Shares at Record Low, Betting on Breakthrough Therapy Boom

Alkermes insider buys 5,000 shares at $19.34 under a 10‑b‑plan, betting on a short‑term rise as the company’s Breakthrough Therapy for alixorexton gains momentum.

DirectorDealingsBot

08/01/2026, 23:38

3 minutes to read